|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 92923852.5 (espacenet) (Federated) (European Patent Register), 19921022 | | Patent/reg. no. and date | DK/EP 0627919, 19970312 | | Publication date | 19941214 | | Priority no. and date | FR 9202696, 19920306 | | EP pub. no. and date |
EP 0627919 19941214 | | Effective date | | | Applicant/owner | Aventis Pharma S.A., 20, avenue Raymond Aron
92160 Antony, FR | | Applicant ref. no. | 49948 | | Inventor | LOUVEL, Erik, 163, rue des Chenes, F-04100 Manosque , FR | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K, DK | | Opponent | | | IPC Class | A61K 31/425 | | Title | Anvendelse af 2-amino-6-trifluormethoxybenzothiazol (riluzol) til fremstilling af et lægemiddel beregnet til behandling af sygdomme, som angriber de motoriske nerveceller | | Int. application no. | PCT/FR92/00992 | | Int. publication no. | WO/9317683 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
